期刊文献+

非小细胞肺癌组织中Nanog的表达 被引量:3

Expression of Nanog in non-small cell lung cancer tissue
下载PDF
导出
摘要 目的:检测非小细胞肺癌(NSCLC)组织中Nanog的表达。方法:采用免疫组化及实时荧光定量PCR法分别检测106例NSCLC及10例正常肺组织中Nanog蛋白及mRNA的表达,采用生存分析探讨Nanog蛋白的表达与肺癌患者预后的关系。结果:NSCLC组织中Nanog蛋白的阳性表达率为24.5%(26/106),高于正常肺组织(0%,P=0.114);Nanog蛋白在肺腺癌中的表达明显高于肺鳞状细胞癌(肺鳞癌)(χ2=5.087,P=0.024),随病理级别增加,Nanog蛋白的阳性表达率升高(χ2=6.845,P=0.033);Nanog蛋白的表达与肺鳞癌患者的预后无关(χ2=0.013,P=0.917),肺腺癌患者中Nanog阴性表达者预后较好(χ2=5.352,P=0.020)。NSCLC组织中Nanog mRNA的表达为(0.950±0.183),高于正常肺组织的(0.277±0.190)(F=122.662,P<0.001);随病理级别增加,Nanog mRNA的表达升高(F=4.047,P=0.020)。结论:Nanog的表达与NSCLC的发生发展有关,且Nanog蛋白的表达与肺腺癌的预后有关。 Aim:To investigate the expression of Nanog in non-small cell lung cancer( NSCLC) tissue. Methods:The expressions of Nanog mRNA and protein were detected in the specimens from 106 cases of NSCLC and 10 cases of normal lung tissue by using quantitative real-time PCR and immunohistochemistry,respectively,then the relationship between the expression of Nanog protein and the prognosis of the patients with lung adenocarcinoma( LAC) or lung squmous cell carcinoma( LSCC) was analyzed by log-rank test. Results:The positive expression rate of Nanog protein in NSCLC tissue was24. 5%,higher than that( 0%) in normal lung tissue( P = 0. 114); the positive expression rate of Nanog protein was higher in LAC tissue than that in LSCC tissue and increased with the increase of pathological degree( χ2= 5. 087,6. 845,P 0. 05); in patients with LAC,those with negative expression of Nanog protein had better progonosis( χ2= 5. 352,P =0. 020). The expression level of Nanog mRNA in NSCLC tissue was( 0. 950 ± 0. 183),higher than that( 0. 277 ± 0. 190)in normal lung tissue( F = 122. 662,P 0. 001); the expression level of Nanog mRNA increased with the increase of pathological degree( F = 4. 047,P = 0. 020). Conclusion:Nanog expression is relevant to the carcinogenesis and development of NSCLC,besides,the expression of Nanog protein is associated with the prognosis of patients with LAC.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2013年第6期758-761,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 广西壮族自治区卫生厅计划课题Z2011171
关键词 非小细胞肺癌 NANOG 预后 non-small cell lung cancer Nanog prognosis
  • 相关文献

参考文献16

  • 1Huntly B J, Gilliland DG. Cancer biology: summing up cancer stem cells [ J ]. Nature,2005, 435 (7046) : 1169.
  • 2Chambers I, Colby D, Robertson M, et al. Functional ex- pression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells[J]. Ce11,2003, 113(5) :643.
  • 3Mak VC, Siu MK, Wong OG, et al. Dysregulated stem- ness-related genes in gynecological malignancies[ J]. His- tol Histopathol, 2012, 27(9) :1121.
  • 4郑文博,潘凌霄,唐炜,高进,叶熹罡.乳腺癌干细胞的培养及鉴定[J].南方医科大学学报,2011,31(12):2021-2025. 被引量:17
  • 5中华病理学杂志编辑委员会.《全国免疫组织化学技术与诊断标准化专题研讨会》会议纪要[J].中华病理学杂志,1996,25(6):326-328.
  • 6陈正堂,朱波.肿瘤学专业现状与发展设想[J].解放军医学杂志,2011,36(4):315-318. 被引量:7
  • 7Yang X, Hou J, Han Z, et al. One cell, muhiple roles: contribution of mesenchymal stem cells to tumor develop- ment in tumor m!croenvironment[J]. Cell Biosci,2013, 3 (1) :5.
  • 8孙中帅,雷建园,广茜茜,畅继武.人Sox2和Nanog基因的克隆及其对胎肺成纤维细胞分化的影响[J].解放军医学杂志,2011,36(11):1145-1148. 被引量:2
  • 9Li XQ, Yang XL, Zhang G, et al. Nuclear 15-catenin ac- cumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lungcancer[J]. JTranslMed, 2013, 11:114.
  • 10Hassan KA, Chen G, Kalemkerian GP, et al. An embry- onic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma [J]. Clin CancerRes, 2009, 15(20) :6386.

二级参考文献38

  • 1Guangjin Pan,James A Thomson.Nanog and transcriptional networks in embryonic stem cell pluripotency[J].Cell Research,2007,17(1):42-49. 被引量:52
  • 2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a p rimitive hematopoietic cell[J]. N ature Med, 1997, 3(7): 730-737.
  • 3Diehn M, Cho RW, Clarke MF. Therapeutic implications of the cancer stem cell hypothesis[J]. Semin Radiat Oncol, 2009, 19(2) : 78-86.
  • 4Kvinlaug BT, Huntly BJ. Targeting cancer stem eei1s[J]. Expert Opin Ther Targets, 2007, 11(7) : 915-927.
  • 5Zhang B, Pan X, Anderson TA. MicroRNA: a new player in stem cells[J]. J Cell Physiol, 2006, 209(2) : 266-269.
  • 6Croce CM, Calin GA. miRNAs, cancer, and stem cell division[J]. Cell, 2005, 122(1) : 6-7.
  • 7Tan FL, Yin JQ, Application of RNAi to cancer research and therapy[J]. Front Biosci, 2005, 10: 1946-1960.
  • 8Wang SL, Yao HH, Qin ZH. Strategies for short hairpin RNA delivery in cancer gene therapy[J]. Expert Opin Biol Ther, 2009, 9(11) : 1357-1368.
  • 9Quon K, Kassner PD. RNA interference screening for the discovery of oncology targets[J]. Expert Opin Ther Targets, 2009, 13(9) :1027-1035.
  • 10Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy[J]. Cancer Gene Ther, 2008, 15 (6) : 341-355.

共引文献74

同被引文献32

  • 1Liu D, Zhou P, Zhang L, et al. HDAC1/DNMT3A-containing complex is associated with suppression of Nanog in cervical cane er cells[J]. Biochemistry (Mosc), 2012,77(8) :934-940.
  • 2Li X, Wang J, Xu Z, et al. Expression of sox2 and Nanog and their clinical significance in human non-small cell lung cancer[J]. Int J Mol Sci,2012,13(6) :7663-7675.
  • 3Hasibeder A, Venkataramani V, Thelen P, et al. Phytoestrogens regulate the proliferation and expression of stem cell factors in cell lines of malignant testicular germ cell tumors[J]. Int J On- col, 2013,43(5) :1385-1394.
  • 4Kim D,Lee da H, Choi J, et al. Validation of tumor markers in central nervous system germ cell tumors by real time reversetranscriptase polymerase chain reaction using formalin-fixed par- affin-embedded tissues[J]. Mol Med Rep, 2013,7(1) :337-341.
  • 5Higgins DM, Wang R, Milligan B, et al. Brain tumor stem cell multipotency correlates with nanog expression and extent of pas- saging in human glioblastoma xenografts[J]. Oncotarget, 2013, 4(5) :792-801.
  • 6Watanabe M, Ohnishi Y, Inoue H, et al. NANOG expression correlates with differentiation, metastasis and resistance to pre operative adjuvant therapy in oral squamous cell carcinoma[J]. Oncol Lett,2014,7(1) :35-40.
  • 7Kirita K, Ishii G, Matsuwaki R, et al. Identification of biologi cal properties of intralymphatie tumor related to the development of lymph node metastasis in lung adenocarcinoma [J]. PLoS One,2013,8(12) :89-99.
  • 8Liu Y, Zhang C, Fan J, et al. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer[J]. Word J Surg Oncol,2011,9(16) :121-128.
  • 9Ting Lin,Yan-Qing Ding,Jian-Ming Li.Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma[J].Medical Oncology.2012(2)
  • 10Carla F. Bender Kim,Erica L. Jackson,Amber E. Woolfenden,Sharon Lawrence,Imran Babar,Sinae Vogel,Denise Crowley,Roderick T. Bronson,Tyler Jacks.??Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer(J)Cell . 2005 (6)

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部